Searched for
TATVA CHINTAN PHARMA Q4 EARNINGS
Rs 8L cr richer! Sensex zooms 1,100 pts, Nifty tops 24K. US-Iran truce among 5 drivers behind bull runIndian equities experienced a robust start to the week, with the Sensex and Nifty surging over 1.5% each. This rally was fueled by an Iran-...- Explained: How SpaceX’s $75 billion IPO could create opportunity for Inox India shareholdersAs Elon Musk's SpaceX heads for a blockbuster IPO, investors are turning their attention to INOX India, a cryogenic technology specialist w...
- Zee Entertainment shares rise over 3% ahead of FIFA World Cup, Rs 2,300-crore fundraising plansZee Entertainment Enterprises' shares rose after its board approved raising at least Rs 2,300 crore to fund strategic initiatives and bolst...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
- SpaceX IPO a bid too far? Some opt for a proxy play with Inox IndiaInox India shares surged following reports of a massively oversubscribed SpaceX IPO, drawing investor attention to the Indian company as a ...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- India's current account deficit to stand at 1.8% of GDP for FY27: ICICI Bank Global Market ReportIndia is expected to see a current account deficit of 1.8 per cent of GDP in FY27 as against around 2 per cent projected earlier. This adju...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Q4 FY26 earnings: Metal companies lead growth, backed by robust volumes and favourable pricing trendsET Wealth presents an 8-quarter earnings assessment report of various sectors. The year-on-year net profit growth for 18 sectors is present...
- Nestle among Nuvama's top 5 consumer picks after Q4 earnings season. Do you own any?Nestle is among Nuvama's top consumer picks following strong Q4 earnings, driven by resilient rural and urban demand. Despite challenges li...
- The AI play no one is talking about: Why BofA is snapping up power & metals instead of ITBofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...
- Groww shares gain 3% as Goldman Sachs buys stake in Rs 210-crore block dealBillionbrain Garage Ventures, parent of Groww, saw its shares rally 3% after Goldman Sachs acquired over 1.13 crore shares for Rs 210.43 cr...
- Earnings slowdown in FY27? JM Financial lists 5 sectors which must do the heavy liftingNifty 50 earnings growth fell short of expectations in FY25 and FY26. While Q4 FY26 results led to an upward revision for FY27E Nifty 50 EP...
- Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...
- Pankaj Pandey identifies defence, pharma and consumption as core stock picking themesIndian equities face a mixed outlook due to potential monsoon deficit and uneven corporate earnings. While rural-linked sectors may see pre...
- Buy financials, healthcare, and manufactured exports; Pramod Gubbi on investing in a tricky marketIndia's Q4 earnings show recovery signs, with Nifty 100 profits up 13%. However, macro headwinds like rising crude oil prices and a depreci...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Asian Paints Q4 Results: Net profit surges 69% YoY to Rs 1,172 crore, revenue rises 11%Asian Paints announced strong Q4 FY26 results. Net profit surged 69% to Rs 1,172 crore. Revenue from operations grew 11% to Rs 9,228.46 cro...
- Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PATA select group of 19 large-cap BSE-listed companies achieved triple-digit growth in both profit and revenue during Q4FY26, indicating stron...
Load More
